Study Proposes Use of AI to Diagnose Autism Spectrum Disorder

Diagnosing autism spectrum disorder (ASD) is still a daunting challenge because of the degree of complexity involved, requiring highly specialized professionals. Autism is a multifactorial neurodevelopment disorder with widely varying symptoms. In the United States, about 1 in 36 children have been diagnosed with ASD, according to the Centers for Disease Control and Prevention (CDC), and yet there are no biochemical markers to identify it with precision. A quantitative diagnostic method is proposed by Brazilian researchers in an article published in the journal Scientific Reports.

The study was based on brain imaging data for 500 people, about half of whom (242) had been diagnosed with ASD. Machine learning techniques were applied to the data. "We began developing our methodology by collecting functional magnetic resonance imaging [fMRI] and electroencephalogram [EEG] data," said Francisco Rodrigues, last author of the article. He is a professor at the University of São Paulo's Institute of Mathematics and Computer Science (ICMC-USP) in São Carlos, Brazil, and his contribution to the research was supported by FAPESP.

"We compared maps of people with and without ASD and found that diagnosis was possible using this methodology," Rodrigues said.

The researchers fed a machine learning algorithm with these maps. Based on the learned examples, the system was able to determine which brain alterations were associated with ASD with above 95% accuracy.

Much recent research proposes methods for diagnosing ASD based on machine learning but uses a single statistical parameter, ignoring brain network organization, which is the innovation featured by this study, the article notes. Brain maps or cortical networks show how brain regions are connected. Research on these networks began about 20 years ago and has offered a new vision of neuroscience. "Just as a road with interruptions alters the traffic in a region, a brain with alterations leads to changes in behavior," Rodrigues said.

The analysis of fMRI data highlighted changes in certain brain regions associated with cognitive, emotional, learning and memory processes. The cortical networks of ASD patients displayed more segregation, less distribution of information and less connectivity compared to controls.

"Until a few years ago, little was known about the alterations that lead to the symptoms of ASD. Now, however, brain alterations in ASD patients are known to be associated with certain behaviors, although anatomical research shows that the alterations are hard to see, making diagnosis of mild ASD much harder. Our study is an important step in the development of novel methodologies that can help us obtain a deeper understanding of this neurodivergence," Rodrigues said.

The methodology is under development and will take years to implement. Nevertheless, it will contribute to the understanding of cerebral differences and will be useful in future to assist specialists, especially in cases involving diagnostic uncertainty.

A wide range of applications

For Rodrigues, the study is a small contribution to a deeper understanding of how ASD relates to brain alterations. Much more research is needed for this automatic diagnostic method to be put into practice. Brain mapping can be useful to diagnose other conditions apart from ASD. Previous work shows that brain maps can also be used to detect schizophrenia with considerable accuracy.

"We began developing novel methods to identify mental disorders a decade ago. We found that the diagnosis of schizophrenia can be much improved using brain networks and artificial intelligence. We also recently studied use of the methodology to investigate Alzheimer's disease and found accurate automatic diagnosis to be possible," Rodrigues said, referring to a study reported in 2022 in the Journal of Neural Engineering.

Many challenges have to be surmounted, such as small databases and the difficulty of collecting data, but as a general methodology it can help scientists understand several conditions, and one of the group’s goals is investigating the relationships among mental disorders.

"How similar in terms of brain alterations are schizophrenia and Alzheimer's? If we can find correlations between mental disorders, we may be able to develop novel medications and similar treatments for different conditions, or even adapt treatment for one condition to use in another. We're a long way from this, but the path ahead is promising," Rodrigues said.

The researchers expect a better understanding of how brain alterations influence behavior to lead to more humane and efficient treatment as well as more effective public policies. The complexity of the subject is evident from the interdisciplinary nature of the research involved. The group comprised physicists, statisticians, physicians and neuroscientists from centers in Brazil, France and Germany. They analyzed medical data compiled by neurologists and brain imaging studies by neuroscientists, as well as algorithms developed by physicists and statisticians.

The study was part of the PhD research of Caroline Alves, first author of the article. Her background is in physics, physical and biomolecular sciences, and computer science. FAPESP also supported two other authors of the article via PhD scholarships: Aruane Pineda (grant no. 19/22277-0) and Kirstin Roster (grant no. 19/26595-7), both of whom were supervised by Rodrigues.

Alves CL, Toutain TGLO, de Carvalho Aguiar P, Pineda AM, Roster K, Thielemann C, Porto JAM, Rodrigues FA.
Diagnosis of autism spectrum disorder based on functional brain networks and machine learning.
Sci Rep. 2023 May 18;13(1):8072. doi: 10.1038/s41598-023-34650-6

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...